Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors
Abstract Background Immune checkpoint inhibitors (ICIs) are a cornerstone of modern cancer treatment, but their effectiveness is limited. Fecal microbiota transplantation (FMT), which alters the gut microbiome, has shown promise in enhancing ICIs’ therapeutic effects. Methods We conducted a comprehe...
Saved in:
| Main Authors: | Anqi Lin, Lihaoyun Huang, Aimin Jiang, Lingxuan Zhu, Weiming Mou, Yu Li, Chunyan Zhang, Zaoqu Liu, Jian Zhang, Quan Cheng, Ting Wei, Peng Luo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | BMC Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12916-025-04183-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice
by: Xinmeng Wang, et al.
Published: (2025-04-01) -
Immune Checkpoints in B Cells: Unlocking New Potentials in Cancer Treatment
by: Xiaoye Shi, et al.
Published: (2024-12-01) -
Comparison of fecal microbiota and metabolites in diarrheal piglets pre-and post-weaning
by: Tao Huang, et al.
Published: (2025-06-01) -
Fecal microbiota transplantation: present and future
by: Ra Ri Cha, et al.
Published: (2025-05-01) -
The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy
by: Yingheng Situ, et al.
Published: (2025-05-01)